Novel collectin
AssigneeFuso Pharmaceutical Industries, Ltd.
InventorNobutaka Wakamiya
Life of this patent
Estimating the term…
Abstract
Novel collectin related molecules i.e., a novel collectin gene comprising a nucleotide sequence set out in SEQ ID NO: 1, and a novel collectin comprising an amino acid sequence set out in SEQ ID NO: 2, which are expected to exhibit anti-bacterial, anti-viral activity or the like especially in human body, and methods in which these molecules are used are provided.
Claims20
1-37. (canceled)
A polypeptide consisting of amino acids 229 to 547 set out in SEQ ID NO:2, wherein the polypeptide binds to a carbohydrate chain in a calcium ion (Ca2+)-specific manner.
A polypeptide consisting of amino acids 226 to 547 set out in SEQ ID NO:2, wherein the polypeptide binds to a carbohydrate chain in a calcium ion (Ca2+)-specific manner.
A polypeptide consisting of amino acids 211 to 547 set out in SEQ ID NO:2, wherein the polypeptide binds to a carbohydrate chain in a calcium ion (Ca2+)-specific manner.
A polypeptide consisting of amino acids 206 to 547 set out in SEQ ID NO:2, wherein the polypeptide binds to a carbohydrate chain in a calcium ion (Ca2+)-specific manner.
A polypeptide consisting of amino acids 102 to 547 set out in SEQ ID NO:2, wherein the polypeptide binds to a carbohydrate chain in a calcium ion (Ca2+)-specific manner.
A polypeptide consisting of amino acids 91 to 547 set out in SEQ ID NO:2, wherein the polypeptide binds to a carbohydrate chain in a calcium ion (Ca2+)-specific manner.
A polypeptide consisting of amino acids 9 to 547 set out in SEQ ID NO:2, wherein the polypeptide binds to a carbohydrate chain in a calcium ion (Ca2+)-specific manner.
A polypeptide consisting of amino acids 1 to 547 set out in SEQ ID NO:2, wherein the polypeptide binds to a carbohydrate chain in a calcium ion (Ca2+)-specific manner.
Dependencies are inferred from the claim text.